1 year return (CAGR)
57.22%
Eupraxia Pharmaceuticals Inc. Common Stock Exchange (NASDAQ, USD)
EPRX
8.38
+0.29 (+3.58%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
553.69M
Price/Sales
-
Ent value
511.58M
Price/Book
4.28
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
34.05%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.30 |
| Daily high | 8.43 |
| Daily low | 8.26 |
| Daily Volume | 258K |
| All-time high | 9.07 |
| 1y analyst estimate | 16.35 |
| Beta | 1.50 |
| EPS (TTM) | -0.76 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| EPRX | S&P500 | |
| Current price drop from All-time high | -7.61% | -1.96% |
| Highest price drop | -35.94% | -56.47% |
| Date of highest drop | 24 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -12.86% | -10.68% |
| Avg time to new high | 21 days | 12 days |
| Max time to new high | 157 days | 1805 days |
News
